Conference report [Conferences / Workshops]

posted by Helmut Homepage – Vienna, Austria, 2023-08-20 10:23 (101 d 00:15 ago) – Posting: # 23703
Views: 1,607

Dear all,

The pre-print was recently published.1

Quote from Section

A vast majority2 of the attendees preferred applying scaling procedures also to AUC, obviously supporting the concept that HVDs need to have a broad therapeutic range. Application of widening to AUC would be a major step towards increasing the concordance rate among US-FDA, HC and EMA. The majority of meeting participants think that the regulatory agencies should give a clear recommendation on the method to be used for BE evaluation of HVD products. Some participants suggested that recommendations on the scaling method and the PK parameters for which scaling should be allowed may be included in product-specific guidances (PSGs). This proposal would allow for a scientifically based BE approach considering the pharmacological aspects of a certain drug or drug class and the clinical relevance of the endpoint.

  1. Mehta M, Schug B, Blume HH, Beuerle G, Jiang W, Koenig J, Paixão P, Tampal N, Tsang Y-C, Walstab J, Wedemeyer R, Welink J. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference. Europ. J. Pharm. Sci. 15 August 2023. doi:10.1016/j.ejps.2023.106566. [image] Open access PDF.
  2. According to the supplementary material 84%.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,811 posts in 4,783 threads, 1,642 registered users;
24 visitors (0 registered, 24 guests [including 6 identified bots]).
Forum time: 09:39 CET (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz